Long-Term Safety/Tolerability of Lanreotide Autogel/Depot (LAN) in Neuroendocrine Tumors (NETs) Patients With Carcinoid Syndrome (CS): The ELECT Long-Term Open-label Extension

Long-Term Safety/Tolerability of Lanreotide Autogel/Depot (LAN) in Neuroendocrine Tumors (NETs) Patients With Carcinoid Syndrome (CS): The ELECT Long-Term Open-label Extension Meeting Abstract

authors

Vinik, Aaron I.

publication date

March 1, 2017

webpage

Web of Science

published in

PANCREAS Journal

start page

437

end page

437

volume

46

issue

3